Equities

Thermogenesis Holdings Inc

Thermogenesis Holdings Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.5695
  • Today's Change-0.050 / -8.00%
  • Shares traded5.46k
  • 1 Year change-57.66%
  • Beta2.3839
Data delayed at least 15 minutes, as of May 28 2024 20:20 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. The Company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The Company markets and sells its medical device products through independent distributors.

  • Revenue in USD (TTM)9.61m
  • Net income in USD-14.75m
  • Incorporated1986
  • Employees25.00
  • Location
    Thermogenesis Holdings Inc2711 Citrus RdRANCHO CORDOVA 95742-6228United StatesUSA
  • Phone+1 (916) 858-5100
  • Fax+1 (916) 858-5199
  • Websitehttps://thermogenesis.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
SeqLL Inc0.00-5.00m1.18m7.00---------13.49-13.490.00-1.100.00----0.00-84.66-71.97-128.28-106.09--61.01---1,471.82----1.40---100.00---37.43------
Rouchon Industries Inc3.55m96.12k1.64m--16.771.3412.300.46320.00430.00430.15770.0535----------12.59--16.3643.5738.242.714.441.527.190.13870.0014.486.66117.924.5364.73--
3DX Industries Inc395.19k-688.11k2.10m0.00------5.31-0.0182-0.01820.0104-0.06530.4891--16.73---85.16-286.11----92.78---174.12-1,759.99---2.54-----2.83--19.39------
Telkonet Inc8.45m-1.29m2.54m35.00--0.8698--0.301-0.0044-0.00440.02850.01541.233.985.07---18.71-24.56-36.26-41.2849.7545.83-15.21-23.542.25-52.910.00--34.640.3964-211.35---16.17--
LumiraDx Ltd126.52m-338.03m3.24m1.21k------0.0256-1.08-1.080.4021-1.310.27651.792.44104,557.90-73.83---96.82---80.48---267.03--1.01-10.512.14---39.62---343.67------
Signal Advance Inc800.00-234.65k3.32m0.00--1.89--4,149.96-0.0056-0.00560.000020.03810.0001-------3.9114.53-4.0815.13-----29,331.2573.68----0.00------11.34------
Reflect Scientific Inc1.27m-343.17k3.94m7.00--2.12--3.11-0.004-0.0040.01480.02170.51290.61845.72181,111.40-13.8811.10-16.4313.2156.0662.48-27.0710.002.21--0.00---47.09-6.99-613.46------
US Nuclear Corp2.23m-3.44m4.35m--------1.95-0.0949-0.09490.0621-0.04940.7480.69036.44---115.12-93.36---392.4341.4346.78-153.91-119.560.1067-0.97888.81--6.68-9.30-66.73---31.69--
Thermogenesis Holdings Inc9.61m-14.75m4.53m25.00--4.65--0.4713-4.99-4.993.140.12260.64423.259.13384,400.00-105.49-78.08-221.76-133.9421.1029.01-163.77-133.660.3739-0.80281.35---9.90-0.4739-59.49--6.96--
Telesis Bio Inc24.63m-47.13m5.97m137.00------0.2422-28.31-28.3114.8012.940.32313.275.58179,802.90-59.34---67.10--60.43---183.66--3.08-35.890.2015--0.2697---1.14------
Precipio Inc15.81m-4.90m8.68m51.00--0.6617--0.5493-3.73-3.7311.608.930.877317.8517.93310,039.20-27.20-44.98-34.82-58.6839.1428.80-31.00-118.070.6201-350.950.0278--61.4639.6252.04--5.37--
Lifeloc Technologies Inc9.32m-24.41k9.82m37.00--1.6244.821.05-0.0099-0.00993.802.481.121.8314.33251,850.30-0.29250.2981-0.33540.340542.2840.75-0.2620.32451.89--0.166--9.992.03145.11-1.09-54.22--
Electro-Sensors Inc8.75m330.00k13.88m35.0042.141.0132.741.590.09610.09612.554.020.60952.487.03250,114.302.301.242.431.2949.1552.433.772.0215.41--0.00---5.252.68175.00--16.95--
Data as of May 28 2024. Currency figures normalised to Thermogenesis Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

2.24%Per cent of shares held by top holders
HolderShares% Held
Raymond James & Associates, Inc. (Invt Mgmt)as of 31 Mar 202465.00k0.82%
The Vanguard Group, Inc.as of 31 Mar 202435.42k0.45%
Virtu Americas LLCas of 31 Mar 202426.45k0.33%
Citadel Securities LLCas of 31 Mar 202416.20k0.20%
Geode Capital Management LLCas of 31 Mar 202410.28k0.13%
Morgan Stanley & Co. LLCas of 31 Mar 20249.27k0.12%
Tower Research Capital LLCas of 31 Mar 20247.27k0.09%
UBS Securities LLCas of 31 Mar 20246.82k0.09%
BlackRock Fund Advisorsas of 31 Mar 20241.49k0.02%
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 202427.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.